Key result
In patients with obesity, both ischaemia (HR 2.14; 95% CI 1.30-3.50) and LGE (HR 3.09; 95% CI 1.83-5.22) on stress CMR were strongly associated with cardiovascular death and non-fatal MI.
Why the study?
Non-invasive assessment and risk stratification of CAD in patients with large body habitus is challenging, prompting evaluation of whether BMI modifies the prognostic value and diagnostic utility of stress CMR.
Does elevated BMI modify the prognostic value and diagnostic utility of stress CMR in intermediate-risk patients?
Cohort (n=2,345)
Yes
Does elevated BMI modify the prognostic value and diagnostic utility of stress CMR in intermediate-risk patients?
Hazard Ratio: 2.14 (95% CI 1.3–3.5)
p-value: p=0.003
Elevated BMI does not negatively impact the diagnostic quality or prognostic effectiveness of stress CMR in intermediate-risk patients.
Stress CMR retains prognostic value in obesity; extends prior data but leaves open need for prospective validation.
AIMS: Non-invasive assessment and risk stratification of coronary artery disease in patients with large body habitus is challenging. We aim to examine whether body mass index (BMI) modifies the prognostic value and diagnostic utility of stress cardiac magnetic resonance imaging (CMR) in a multicentre registry. METHODS AND RESULTS: The SPINS Registry enrolled consecutive intermediate-risk patients who presented with a clinical indication for stress CMR in the USA between 2008 and 2013. Baseline demographic data including BMI, CMR indices, and ratings of study quality were collected. Primary outcome was defined by a composite of cardiovascular death and non-fatal myocardial infarction. Of the 2345 patients with available BMI included in the SPINS cohort, 1177 (50%) met criteria for obesity (BMI ≥ 30) with 531 (23%) at or above Class 2 obesity (BMI ≥ 35). In all BMI categories, >95% of studies were of diagnostic quality for cine, perfusion, and late gadolinium enhancement (LGE) sequences. At a median follow-up of 5.4 years, those without ischaemia and LGE experienced a low annual rate of hard events (<1%), across all BMI strata. In patients with obesity, both ischaemia [hazard ratio (HR): 2.14; 95% confidence interval (CI): 1.30-3.50; P = 0.003] and LGE (HR: 3.09; 95% CI: 1.83-5.22; P < 0.001) maintained strong adjusted association with the primary outcome in a multivariable Cox regression model. Downstream referral rates to coronary angiography, revascularization, and cost of care spent on ischaemia testing did not significantly differ within the BMI categories. CONCLUSION: In this large multicentre registry, elevated BMI did not negatively impact the diagnostic quality and the effectiveness of risk stratification of patients referred for stress CMR.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2020) conducted a cohort in Coronary artery disease (n=2,345). Ischaemia and late gadolinium enhancement (LGE) on stress CMR vs. No ischaemia and no LGE was evaluated on Composite of cardiovascular death and non-fatal myocardial infarction (HR 2.14, 95% CI 1.30-3.50, p=0.003). In patients with obesity, both ischaemia (HR 2.14; 95% CI 1.30-3.50) and LGE (HR 3.09; 95% CI 1.83-5.22) on stress CMR were strongly associated with cardiovascular death and non-fatal MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: